Dutch Bros shows off its growth plans at the ICR Conference

[ad_1] Juanmonino/E+ via Getty Images InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress. The European Commission granted marketing authorization under exceptional circumstances for Gohibic, also known as vilobelimab, for the treatment of adult patients [ad_2]

[ad_1] Jan. 17, 2025 11:58 AM ETAMGN, GSK, BMY, PFE, NVO, MRK, TEVA, AZN, BHC, ALPMF, ALPMY, IRWD, ABBVBy: Dulan Lokuwithana, SA News Editor wildpixel/iStock via Getty Images As Medicare announced a fresh set of drugs selected for its price-setting process on Friday under the Inflation Reduction Act, industry group PhRMA criticized the landmark legislation,…